Session Details
[K2]Kick-off Meeting for the MCM Program 2
Wed. Jul 8, 2026 2:50 PM - 3:32 PM JST
Wed. Jul 8, 2026 5:50 AM - 6:32 AM UTC
Wed. Jul 8, 2026 5:50 AM - 6:32 AM UTC
Ito Hall( Ito International Research Center B2)
Chair:Takeshi Inoue, Satoru NAGATOISHI
[K2-01]CRISPR-Cas3-based diagnostic platform for rapid pandemic response
*Tomoji Mashimo1 (1. Division of Animal Genetics, Institute of Medical Science, The University of Toky (Japan))
[K2-02]Technological development of next-generation diagnostic and therapeutic modalities for infectious diseases using protein engineering
*Satoru NAGATOISHI1, Ryo MATSUNAGA1, Makoto NAKAKIDO1, Kouhei TSUMOTO1 (1. School of Engineering, The University of Tokyo (Japan))
[K2-03]In-situ fabrication of ultra-conformal nanomesh epidermal sensors on arbitrary skin surface
*Xiaoping Liang1, Tomoyuki Yokota1, Takao Someya1 (1. Department of Electrical Engineering and Information Systems, The University of Tokyo (Japan))
[K2-04]Current approarch and Upcoming Initiatives in GMP training for Vaccine researchers
*Shingou Sakurai1, Atsushi Iwakaji1, Eriko Komori1, Hiroshi Sakurai1, Hitoshi Takayashiki1, Osamu Kawamata1, Saeko Takamatsu1, Noboru Aoki1, Miyuki Takahashi1, Ryoko Naruse2, Noriyuki Nakajima2, Hironao Ueno2 (1. Faculty of Pharmaceutical Science, Tokyo University of Science (Japan), 2. Laboratory of Biopharmaceutical Human Resource Development for Manufacturing and Quality Assurance, Toyama Prefectural University (Japan))
[K2-05]Support for the Clinical Development and Clinical Trials of Vaccines and Other Medical Countermeasures
*Fumitaka Nagamura1 (1. Division of Advanced Medicine Promotion, The Institute of Medical Science, The University of Tokyo (Japan))
[K2-06]Strategic development of novel antimicrobial agents targeting biomarker enzymatic activities
*Yasuteru Urano1 (1. Graduate School of Pharmaceutical Sciences and Graduate School of Medicine, The University of Tokyo (Japan))